Survival time analysis methodology. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Cells, Cultured Cell Line Tumor Cells, Cultured Spleen Bile Ducts, Intrahepatic Brain Liver Lymph Nodes Lung T-Lymphocytes Neurons

Organisms10

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Nude Mice, Knockout Mice, Inbred Strains Mice, Transgenic Mice, SCID Dogs Rats, Sprague-Dawley Mice, Inbred DBA

Diseases48

Lung Neoplasms Brain Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Disease Progression Breast Neoplasms Glioblastoma Carcinoma, Hepatocellular Colorectal Neoplasms Stomach Neoplasms Disease Models, Animal Pancreatic Neoplasms Lymphatic Metastasis Carcinoma, Squamous Cell Glioma Neoplasms Carcinoma Ovarian Neoplasms Melanoma Neoplasm Invasiveness Carcinoma, Small Cell Bile Duct Neoplasms Recurrence Esophageal Neoplasms Cholangiocarcinoma Supratentorial Neoplasms Bone Neoplasms Kidney Neoplasms Dog Diseases Pleural Neoplasms Neoplasms, Experimental Prostatic Neoplasms Leukemia L1210 Mesothelioma Carcinoma, Renal Cell Colonic Neoplasms Multiple Myeloma Peritoneal Neoplasms Astrocytoma Skin Neoplasms Postoperative Complications Lymphoma Rectal Neoplasms Osteosarcoma Head and Neck Neoplasms

Chemicals and Drugs42

Antineoplastic Agents Cisplatin Tumor Markers, Biological Fluorouracil Deoxycytidine Doxorubicin Cyclophosphamide Antimetabolites, Antineoplastic Paclitaxel Vincristine Etoposide Nimustine Antibodies, Monoclonal Leucovorin Camptothecin Carboplatin Antineoplastic Agents, Phytogenic RNA, Messenger Dacarbazine Organoplatinum Compounds Taxoids Vinblastine Antineoplastic Agents, Alkylating Prednisone Immunosuppressive Agents Neoplasm Proteins Tegafur Methotrexate Antibodies, Monoclonal, Humanized Oxonic Acid Oxyquinoline Recombinant Proteins Tumor Suppressor Protein p53 Proto-Oncogene Proteins Vindesine Ki-67 Antigen Survival of Motor Neuron 1 Protein Cytarabine Receptor, Epidermal Growth Factor RNA, Small Interfering Drug Combinations Cytokines

Analytical, Diagnostic and Therapeutic Techniques and Equipment90

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Prognosis Kaplan-Meier Estimate Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Proportional Hazards Models Combined Modality Therapy Follow-Up Studies Immunohistochemistry Multivariate Analysis Drug Administration Schedule Risk Factors Prospective Studies Disease Models, Animal Cohort Studies Chemotherapy, Adjuvant Transplantation, Homologous Predictive Value of Tests Neoplasm Transplantation Palliative Care Gene Expression Profiling Risk Assessment Models, Statistical Reverse Transcriptase Polymerase Chain Reaction Models, Biological Reproducibility of Results Remission Induction Skin Transplantation Infusions, Intravenous Registries Radiotherapy Dosage Life Tables Radiotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Heart Transplantation Probability Blotting, Western Chemoembolization, Therapeutic Clinical Trials as Topic Analysis of Variance Actuarial Analysis Liver Transplantation Regression Analysis Salvage Therapy Randomized Controlled Trials as Topic Neoplasms, Experimental Incidence Xenograft Model Antitumor Assays Polymerase Chain Reaction Tumor Burden Neoplasm Grading Biostatistics Transplantation, Heterologous Radiotherapy Hepatectomy Kidney Transplantation Dose Fractionation Chi-Square Distribution Karnofsky Performance Status Neoadjuvant Therapy Sensitivity and Specificity Cause of Death Chemoradiotherapy Immunotherapy Research Design Cranial Irradiation Corneal Transplantation Treatment Failure Tissue Array Analysis Life Expectancy Data Interpretation, Statistical Clinical Trials, Phase III as Topic Severity of Illness Index Lethal Dose 50 Random Allocation Immunoenzyme Techniques Injections, Intraperitoneal Statistics, Nonparametric Gastrectomy Case-Control Studies SEER Program Administration, Oral Infusions, Intra-Arterial Patient Selection Drug Therapy, Combination Cluster Analysis

Phenomena and Processes28

Time Factors Cell Survival Graft Survival Apoptosis Signal Transduction Cell Proliferation Graft Rejection Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Mutation Algorithms Probability Phenotype Drug Resistance, Neoplasm Longevity Genotype Chi-Square Distribution Cell Division Sensitivity and Specificity Gene Expression Cell Differentiation Cell Death Lethal Dose 50 Up-Regulation Microbial Viability Base Sequence Phosphorylation Species Specificity

Disciplines and Occupations2

Immunohistochemistry Research Design

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science12

Survival Rate Algorithms Registries Life Tables Molecular Sequence Data Incidence Computer Simulation Cause of Death Life Expectancy Data Interpretation, Statistical SEER Program Base Sequence

Named Groups2

Survivors Infant, Newborn

Health Care43

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Multivariate Analysis Risk Factors Prospective Studies Cohort Studies Age Factors Predictive Value of Tests Palliative Care Risk Assessment Models, Statistical Reproducibility of Results Registries Life Tables Probability Clinical Trials as Topic Analysis of Variance Actuarial Analysis Regression Analysis Randomized Controlled Trials as Topic Incidence Chi-Square Distribution Karnofsky Performance Status Sensitivity and Specificity Cause of Death Treatment Failure Life Expectancy Data Interpretation, Statistical Clinical Trials, Phase III as Topic Sex Factors Severity of Illness Index Random Allocation Statistics, Nonparametric Case-Control Studies SEER Program Patient Selection Cluster Analysis

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Time Factors Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Graft Survival Treatment Outcome Prognosis Kaplan-Meier Estimate Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Lung Neoplasms Proportional Hazards Models Combined Modality Therapy Follow-Up Studies Antineoplastic Agents Brain Neoplasms Cisplatin Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Tumor Markers, Biological Immunohistochemistry Neoplasm Metastasis Multivariate Analysis Carcinoma, Non-Small-Cell Lung Disease Progression Apoptosis Fluorouracil Cell Line, Tumor Breast Neoplasms Drug Administration Schedule Mice, Inbred C57BL Risk Factors Prospective Studies Mice, Inbred BALB C Glioblastoma Deoxycytidine Carcinoma, Hepatocellular Colorectal Neoplasms Stomach Neoplasms Disease Models, Animal Cohort Studies Doxorubicin Pancreatic Neoplasms Cyclophosphamide Signal Transduction Lymphatic Metastasis Carcinoma, Squamous Cell Antimetabolites, Antineoplastic Age Factors Cell Proliferation Glioma Chemotherapy, Adjuvant Graft Rejection Transplantation, Homologous Neoplasms Predictive Value of Tests Carcinoma Ovarian Neoplasms Neoplasm Transplantation Gene Expression Regulation, Neoplastic Paclitaxel Palliative Care Gene Expression Profiling Dose-Response Relationship, Drug Mutation Risk Assessment Vincristine Models, Statistical Reverse Transcriptase Polymerase Chain Reaction Models, Biological Reproducibility of Results Melanoma Etoposide Neoplasm Invasiveness Remission Induction Nimustine Cells, Cultured Antibodies, Monoclonal Carcinoma, Small Cell Bile Duct Neoplasms Recurrence Skin Transplantation Leucovorin Esophageal Neoplasms Camptothecin Algorithms Infusions, Intravenous Carboplatin Registries Cholangiocarcinoma Radiotherapy Dosage Supratentorial Neoplasms Antineoplastic Agents, Phytogenic RNA, Messenger Mice, Nude Life Tables

No FAQ available that match "survival time analysis methodology"